semaglutide glp 1 receptor agonist vs. Tirzepatide: Which GLP-1 Wins? A Review on Semaglutide: An
Description
48 Initial evaluation in healthy humans revealed that oral administration of Danuglipron produced a dose-dependent increase in systemic exposure bioavailability
2023 Sep 7;389(10):877-888
Rehfeld, Jan Fahrenkrug, Jens Holst, Thue Schwartz, Peter Horness, Claus Khl and Ove Schaffalitzky de Muckadell
doi: 10.1210/en.2011-1070
Efficacy was measured by monitoring changes in glycated hemoglobin (HbA1c) and body weight at week 12
Association between glucagon-like peptide-1 receptor agonists and the risk of glaucoma in individuals with type 2 diabetes
